XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Total IPO
Common Shares
Common Shares
Total IPO
Additional Paid-In Capital
Additional Paid-In Capital
Total IPO
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning Balance at Dec. 31, 2020 $ 136,003   $ 2   $ 183,015   $ (47,014)  
Beginning Balance (in shares) at Dec. 31, 2020     23,410,348          
Issuance of common stock under the stock award plan (in shares)       7,130,000        
Issuance of common stock under the stock award plan   $ 82,967   $ 1   $ 82,966    
Share-based compensation expense 2,116       2,116      
Issuance of restricted common stock (in shares)     1,589,622          
Net loss (34,598)           (34,598)  
Other comprehensive loss 0              
Ending Balance (in shares) at Sep. 30, 2021     32,129,970          
Ending Balance at Sep. 30, 2021 186,488   $ 3   268,097   (81,612)  
Beginning Balance at Jun. 30, 2021 112,662   $ 2   184,076   (71,416)  
Beginning Balance (in shares) at Jun. 30, 2021     24,999,970          
Issuance of common stock under the stock award plan (in shares)       7,130,000        
Issuance of common stock under the stock award plan   $ 82,967   $ 1   $ 82,966    
Share-based compensation expense 1,055       1,055      
Net loss (10,196)           (10,196)  
Other comprehensive loss 0              
Ending Balance (in shares) at Sep. 30, 2021     32,129,970          
Ending Balance at Sep. 30, 2021 186,488   $ 3   268,097   (81,612)  
Beginning Balance at Dec. 31, 2021 175,602   $ 3   269,626   (94,027)  
Beginning Balance (in shares) at Dec. 31, 2021     32,129,970          
Issuance of common stock under the stock award plan (in shares)     2,000          
Share-based compensation expense $ 7,205       7,205      
Forfeiture of restricted common stock, shares     (42,586)          
Issuance of common stock from exercise of stock options, shares 2,014   2,014          
Issuance of common stock from exercise of stock options $ 21       21      
Net loss (50,451)           (50,451)  
Other comprehensive loss (434)             $ (434)
Ending Balance (in shares) at Sep. 30, 2022     32,091,398          
Ending Balance at Sep. 30, 2022 131,943   $ 3   276,852   (144,478) (434)
Beginning Balance at Jun. 30, 2022 147,851   $ 3   274,327   (126,108) (371)
Beginning Balance (in shares) at Jun. 30, 2022     32,130,970          
Issuance of common stock under the stock award plan (in shares)     1,000          
Share-based compensation expense 2,504       2,504      
Forfeiture of restricted common stock, shares     (42,586)          
Issuance of common stock from exercise of stock options, shares     2,014          
Issuance of common stock from exercise of stock options 21       21      
Net loss (18,370)           (18,370)  
Other comprehensive loss (63)             (63)
Ending Balance (in shares) at Sep. 30, 2022     32,091,398          
Ending Balance at Sep. 30, 2022 $ 131,943   $ 3   $ 276,852   $ (144,478) $ (434)